Lawmakers push FDA on inspections of foreign pharma plants; cancer drug shortages deliver 'gut punch' to patients

Taking stock of the drug industry, from the lab to the medicine chest

July 19, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Manuel Balce Ceneta/AP STAT+ | House committee probes FDA inspections of pharma plants in China and India The probe highlights long-standing doubts over the ability of the FDA to monitor crucial components of the U.S. pharmaceutical supply chain. By Ed Silverman Cancer drug shortages deliver 'gut punch' to patients unsure if their survival odds will be undercut Mairéad McInerney says she'll never know whether cancer drug shortages affected her odds of beating breast cancer. By Charlotte Huff STAT+ | Bernie Sanders adds three drug shortage policies to pandemic preparedness bill Sen. Sanders added three drug shortage measures to a pandemic-preparedness bill that his committee will consider Thursday. By John Wilkerson Alex Hogan/STAT STAT+ | App developer Twill hunts for pharma partner to market its digital depression treatment App developer Twill will shop around for a pharmaceutical company to market Aspiro, its digital treatment for depression and anxiety. By Mario Aguilar TikTok cracks down on users posting about popular weight loss drugs TikTok is cracking down on users posting about popular weight loss drugs like Ozempic, Wegovy, and Mounjaro. By Katie Palmer

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser